Sheldon L. Koenig - May 17, 2021 Form 4 Insider Report for Esperion Therapeutics, Inc. (ESPR)

Role
President and CEO, Director
Signature
/s/ Richard B. Bartram, by power of attorney
Stock symbol
ESPR
Transactions as of
May 17, 2021
Transactions value $
$0
Form type
4
Date filed
5/18/2021, 05:06 PM
Next filing
Nov 1, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ESPR Common Stock Award $0 +20K +66.67% $0.00 50K May 17, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ESPR Stock Option (right to buy) Award $0 +120K $0.00 120K May 17, 2021 Common Stock 120K $20.87 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Such awards will vest over a four (4) year period as follows: 25% shall vest on the one year anniversary of June 15, 2021 and the remainder shall vest in equal quarterly installments over the three (3) year period thereafter, subject to continued service
F2 Such options will vest over a four (4) year period as follows: 25% shall vest on the one year anniversary of June 15, 2021 and the remainder shall vest in equal quarterly installments over the three (3) year period thereafter, subject to continued service